Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Efficacy and safety observation of luspatercept for refractory anemia associated with hematologic malignanciesluspatercept治疗血液系统恶性肿瘤相关难治性贫血的疗效和安全性观察luspatercept 改善与血液系统恶性肿瘤相关的难治性贫血的疗效和安全性：一项观察

Ping Zhang, Shuling Yu, Shengfa Gao, Huiling Zhu, Shanhao Tang, Yongcheng Sun, Binbin Lai, Xiao Wu, Lieguang Chen, Kaihong Xu, Lixia Sheng, Guifang Ouyang

Blood (2025) 146 (Supplement 1): 2888.

https://doi.org/10.1182/blood-2025-2888

Published: 2025

Journal Articles

Mid-treatment CSF ctdna and MYD88 clearance outperform PET-CT in predicting response and survival to orelabrutinib-based induction in newly diagnosed PCNSL: A prospective biomarker study

Lixia Sheng, Yanli Lai, Sheng Nie, Yuning Pan, Di Wang, Shanhao Tang, Kaihong Xu, Yongcheng Sun, Ping Zhang, Binbin Lai, Lieguang Chen, Guifang Ouyang

Blood (2025) 146 (Supplement 1): 59.

https://doi.org/10.1182/blood-2025-59

Published: 2025

Journal Articles

Multi-omics profiling of the gut Microbiota–Metabolism–Immunity axis reveals predictive biomarkers of treatment response and survival in diffuse large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 3533.

https://doi.org/10.1182/blood-2025-3533

Published: 2025

Journal Articles

Preliminary Data on the Efficacy and Safety of Orelabrutinib Combined with Rituximab and Methotrexate (ORM Regimen) As First-Line Treatment for Primary Central Nervous System Lymphoma, and the Exploration of Cerebrospinal Fluid Ctdna Dynamic Monitoring

Lixia Sheng, Guifang Ouyang, Yanli Lai, Sheng Nie, Di Wang, Shanhao Tang, Yuning Pan, Kaihong Xu, Yongcheng Sun, Ping Zhang, Binbin Lai, Lieguang Chen

Blood (2024) 144 (Supplement 1): 4500.

https://doi.org/10.1182/blood-2024-198355

Published: 2024